NYSE:BMYPharmaceuticals
Should Texas Plavix Lawsuit Prompt Fresh Risk Assessment From Bristol-Myers Squibb (BMY) Investors?
In November 2025, Texas Attorney General Ken Paxton filed a lawsuit against Bristol-Myers Squibb and Sanofi, alleging the companies failed to disclose that their blood thinner Plavix has reduced efficacy in patients of certain ethnic backgrounds due to genetic factors, potentially violating state consumer protection laws. The lawsuit claims millions of Texans were improperly prescribed the medication, raising concerns about patient safety and substantial financial impact on taxpayer-funded...